Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

NCT03455556 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Mesothelin Positive
Stage III Non-Small Cell Lung Cancer AJCC v7
Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Stage IIIB Non-Small Cell Lung Cancer AJCC v7
Stage IV Non-Small Cell Lung Cancer AJCC v7

Interventions

BIOLOGICAL: Anetumab Ravtansine
BIOLOGICAL: Atezolizumab
OTHER: Laboratory Biomarker Analysis

Sponsor

Mayo Clinic

Collaborators

[object Object]